Series Therapeutics Shares Quiet, JMP Securities Issues Mid-Day Note; Says 'Strongly View Results Of Ph2 ECO-RESET Trial For Mild-To-Moderate UC Evaluating SER-287 (two-arms) vs. PBO Is An Isolated Story (that is still evolving)'